Mitchell, D., Archer, G. E., Bigner, D. D., Friedman, H. S., Lally-Goss, D., Herndon, J. E., … Sampson, J. H. (2008). Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM. JOURNAL OF CLINICAL ONCOLOGY, 26(15).

Mitchell, D., G. E. Archer, D. D. Bigner, H. S. Friedman, D. Lally-Goss, J. E. Herndon, S. McGehee, R. McLendon, D. A. Reardon, and J. H. Sampson. “Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM.” JOURNAL OF CLINICAL ONCOLOGY 26, no. 15 (May 20, 2008).

Mitchell D, Archer GE, Bigner DD, Friedman HS, Lally-Goss D, Herndon JE, et al. Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM. JOURNAL OF CLINICAL ONCOLOGY. 2008 May 20;26(15).

Mitchell, D., et al. “Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM.” JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 15, AMER SOC CLINICAL ONCOLOGY, May 2008.

Mitchell D, Archer GE, Bigner DD, Friedman HS, Lally-Goss D, Herndon JE, McGehee S, McLendon R, Reardon DA, Sampson JH. Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2008 May 20;26(15).